Paperpal Prime Logo

Drug Target Insights : Impact Factor & More

eISSN: 1177-3928pISSN: 1177-3928
JournalOpen Access

Aims and Scope of Drug Target Insights

Drug Target Insights (DTI) is an international, indexed, peer-reviewed, open access, online only journal, published once a year. It covers current developments in all areas of the field of clinical therapeutics and focusing on molecular drug targets which include disease-specific proteins, receptors, enzymes, and genes. The journal seeks to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life. The journal welcomes unsolicited article proposals. All articles are listed on PubMed and are freely available via PubMed Central. Less

Key Metrics

CiteScore
4.3
SJR
Q2Clinical Biochemistry
SNIP
0.65
Recommended pre-submission checks
Powered by Paperpal by Editage

Drug Target Insights Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ABOUTSCIENCE SRL
Language English
Frequency Continuous publication
Article Processing ChargesEUR 1500
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Drug Target Insights ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Target Insights

Optimizing ChEMBL-derived QSAR models for natural flavonoid screening: chemotype-specific predictive reliability in \u03b1-glucosidase-inhibition
  • 5 Oct 2026
  • Drug Target Insights
Erratum in: In vitro and molecular docking evaluation of apigenin-7-O-glucuronide from Psorospermum febrifugum as anti-inflammatory and predicted antiplasmodial compound
  • 7 Sep 2026
  • Drug Target Insights
In vitro and molecular docking evaluation of apigenin-7-O-glucuronide from Psorospermum febrifugum as anti-inflammatory and predicted antiplasmodial compound
  • 4 Aug 2026
  • Drug Target Insights
Withania somnifera root extract reduces susceptibility of the model worm Caenorhabditis elegans to different types of stressors
  • 20 Jul 2026
  • Drug Target Insights
Comparative effects of Helmar-1 and Helmar-2 polyphenol extracts on mitochondrial bioenergetics, antioxidant defense, and lipid peroxidation in CCl₄-induced toxic hepatitis in rats.
  • 13 Jul 2026
  • Drug target insights
Molecular docking and dynamics analysis of selected phytocompounds against multi-targeted hepatocellular carcinoma.
  • 23 Apr 2026
  • Drug target insights
Optimizing ChEMBL-derived QSAR models for natural flavonoid screening: chemotype-specific predictive reliability in \u03b1-glucosidase-inhibition
  • 5 Oct 2026
  • Drug Target Insights
Erratum in: In vitro and molecular docking evaluation of apigenin-7-O-glucuronide from Psorospermum febrifugum as anti-inflammatory and predicted antiplasmodial compound
  • 7 Sep 2026
  • Drug Target Insights
In vitro and molecular docking evaluation of apigenin-7-O-glucuronide from Psorospermum febrifugum as anti-inflammatory and predicted antiplasmodial compound
  • 4 Aug 2026
  • Drug Target Insights
Withania somnifera root extract reduces susceptibility of the model worm Caenorhabditis elegans to different types of stressors
  • 20 Jul 2026
  • Drug Target Insights
Comparative effects of Helmar-1 and Helmar-2 polyphenol extracts on mitochondrial bioenergetics, antioxidant defense, and lipid peroxidation in CCl₄-induced toxic hepatitis in rats.
  • 13 Jul 2026
  • Drug target insights
Molecular docking and dynamics analysis of selected phytocompounds against multi-targeted hepatocellular carcinoma.
  • 23 Apr 2026
  • Drug target insights

FAQs on Drug Target Insights